z-logo
open-access-imgOpen Access
A distinct four-value blood signature of pyrexia under combination therapy of malignant melanoma with dabrafenib and trametinib evidenced by an algorithm-defined pyrexia score
Author(s) -
Hannah Schaefer,
Albert Rübben,
André Esser,
Arturo Araujo,
OanaDiana Persa,
Marike M. Leijs
Publication year - 2022
Publication title -
plos one
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.99
H-Index - 332
ISSN - 1932-6203
DOI - 10.1371/journal.pone.0273478
Subject(s) - dabrafenib , medicine , trametinib , melanoma , lactate dehydrogenase , algorithm , gastroenterology , biology , cancer research , vemurafenib , metastatic melanoma , mapk/erk pathway , biochemistry , kinase , computer science , enzyme , microbiology and biotechnology

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom